Nearly 1 million people are living with multiple sclerosis in the United States. Spasticity is a commonly reported symptom for MS, with an estimated prevalence of spasticity of 67%
Arformoterol Tartrate had estimated annual sales of US $ 251 million in the U.S. (IQVIA MAT December 2021)
Key takeaways of recent quarter & conference call highlights
Takes charge to lead business innovation, strategy, alliance & partnerships
Fast, flexible space allows clinical trials to start when needed. A trial can become operational, pivot or scale without traditional capital building expenditures
New instrument helps maximize lab productivity and extends FTIR to large, heavy samples
Highest safety and efficacy of Sputnik V confirmed during clinical trials and in real-world use in more than 60 countries around the world
It has a total of 50 ANDA approvals from USFDA
Caplin Point Laboratories has reported consolidated financial results for the period ended December 31, 2021.
Restasis has been approved for use in the U.S. for nearly 20 years, but until today, there was no approved generic product of this drug
Subscribe To Our Newsletter & Stay Updated
